View ValuationAspial 将来の成長Future 基準チェック /06現在、 Aspialの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Specialty Retail 収益成長14.7%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Aug 12Aspial Corporation Limited Provides Earning Guidance for Half Year Ended 30 June 2023Aspial Corporation Limited provided earning guidance for half year ended 30 June 2023. The Board of Directors announced that following a preliminary review of the unaudited financial results, the Group is expected to report a loss for the half year ended 30 June 2023. The expected loss was due to higher loss incurred for the Group's real estate business. Further details of the Group's financial performance will be disclosed when the Company announces its half year.すべての更新を表示Recent updatesReported Earnings • Apr 17Full year 2025 earnings released: EPS: S$0.01 (vs S$0.002 in FY 2024)Full year 2025 results: EPS: S$0.01 (up from S$0.002 in FY 2024). Revenue: S$875.8m (up 29% from FY 2024). Net income: S$21.5m (up S$18.0m from FY 2024). Profit margin: 2.5% (up from 0.5% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.お知らせ • Apr 16Aspial Corporation Limited (SGX:A30) and Koh Wee Meng completed the acquisition of remaining 20.16% stake in AF Global Limited (SGX:L38).Aspial Corporation Limited (SGX:A30) and Koh Wee Meng entered into an implementation agreement to acquire remaining 20.16% stake in AF Global Limited (SGX:L38) for SGD 23.4 million on October 8, 2025. A cash consideration valued at SGD 0.11 per share will be paid by Aspial Corporation Limited. As at the Joint Announcement Date, Aspial has a direct interest in 440,691,785 Shares, representing 41.75% stake and KWM has a direct interest in 326,265,000 Shares, representing 30.91% stake in AF Global. Based on information available to the Offeror as at the Joint Announcement Date, 75,855,637 Shares representing approximately 7.19% of the total number of Shares are held by persons who are deemed to be “interested persons” (as defined in the listing manual of the SGX-ST) of Aspial. The Related Shareholders are presumed to be concert parties of the Offeror under the Code and will abstain from voting on the Scheme in accordance with the requirements of the Securities Industry Council’s. DBS, as the sole financial adviser to the Offeror, confirms that sufficient financial resources are available to the Offeror to satisfy in full the aggregate Scheme Consideration payable by the Offeror for all the Scheme Shares to be acquired by the Offeror pursuant to the Scheme. The transaction is subject to approval of the Scheme by a majority in number of the Scheme Shareholders representing three-fourths in value of the Scheme Shares held by Scheme Shareholders present and voting either in person or by proxy at the Scheme Meeting, The Offeror and its concert parties, and the common substantial shareholders of the Offeror and the Company will abstain from voting on the Scheme, Court sanction for convening the Scheme Meeting; and (ii) the approval of the Scheme (if approved at the Scheme Meeting). The transaction is expected to complete in first quarter of 2026. As of January 15, 2026, the court has granted approval for the transaction. As of January 15, 2026, AF Global board announced that it has dispatched scheme document to shareholders. Shareholders meeting will be held on February 5, 2026. As of February 4, 2026, AF Global Limited announced the postpone of shareholders meeting from February 5, 2026, to March 10, 2026. As of February 12, 2026, AF Global Limited announced that SGX-ST informed that it has no objection to AF Global Waiver Application. On March 10, 2026, the shareholders of AF Global Limited has approved the transaction. The transaction is now expected to close on or around April 8, 2026. As per the announcement dated March 27, 2026 the court has sanctioned the Scheme. The transaction is now expected to close on April 14, 2026. DBS Bank Ltd. acted as financial advisor for Aspial Corporation and Koh Wee Meng. Xandar Capital Pte. Ltd. acted as financial advisor for AF Global Limited. Evolve Capital Asia acted as financial advisor to directors of Aspial. Venture Law LLC acted as legal advisor for AF Global Limited. Aspial Corporation Limited (SGX:A30) and Koh Wee Meng completed the acquisition of remaining 20.16% stake in AF Global Limited (SGX:L38) on April 15, 2026.New Risk • Apr 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change).お知らせ • Apr 14Aspial Corporation Limited, Annual General Meeting, Apr 28, 2026Aspial Corporation Limited, Annual General Meeting, Apr 28, 2026, at 16:00 Singapore Standard Time. Location: aspial one, 55 ubi avenue 3, level 1, singapore 408864, SingaporeReported Earnings • Feb 26Full year 2025 earnings released: EPS: S$0.01 (vs S$0.002 in FY 2024)Full year 2025 results: EPS: S$0.01 (up from S$0.002 in FY 2024). Revenue: S$875.8m (up 29% from FY 2024). Net income: S$21.5m (up 294% from FY 2024). Profit margin: 2.5% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.分析記事 • Jan 15With Aspial Corporation Limited (SGX:A30) It Looks Like You'll Get What You Pay ForWith a median price-to-sales (or "P/S") ratio of close to 0.7x in the Specialty Retail industry in Singapore, you could...お知らせ • Oct 08Aspial Corporation Limited (SGX:A30) and Koh Wee Meng entered into an implementation agreement to acquire remaining 20.16% stake in AF Global Limited (SGX:L38) for SGD 23.4 million.Aspial Corporation Limited (SGX:A30) and Koh Wee Meng entered into an implementation agreement to acquire remaining 20.16% stake in AF Global Limited (SGX:L38) for SGD 23.4 million on October 8, 2025. A cash consideration valued at SGD 0.11 per share will be paid by Aspial Corporation Limited. As at the Joint Announcement Date, Aspial has a direct interest in 440,691,785 Shares, representing 41.75% stake and KWM has a direct interest in 326,265,000 Shares, representing 30.91% stake in AF Global. Based on information available to the Offeror as at the Joint Announcement Date, 75,855,637 Shares representing approximately 7.19% of the total number of Shares are held by persons who are deemed to be “interested persons” (as defined in the listing manual of the SGX-ST) of Aspial. The Related Shareholders are presumed to be concert parties of the Offeror under the Code and will abstain from voting on the Scheme in accordance with the requirements of the Securities Industry Council’s. DBS, as the sole financial adviser to the Offeror, confirms that sufficient financial resources are available to the Offeror to satisfy in full the aggregate Scheme Consideration payable by the Offeror for all the Scheme Shares to be acquired by the Offeror pursuant to the Scheme. The transaction is subject to approval of the Scheme by a majority in number of the Scheme Shareholders representing three-fourths in value of the Scheme Shares held by Scheme Shareholders present and voting either in person or by proxy at the Scheme Meeting, The Offeror and its concert parties, and the common substantial shareholders of the Offeror and the Company will abstain from voting on the Scheme, Court sanction for convening the Scheme Meeting; and (ii) the approval of the Scheme (if approved at the Scheme Meeting). The transaction is expected to complete in first quarter of 2026. DBS Bank Ltd. acted as financial advisor for Aspial Corporation and Koh Wee Meng. Xandar Capital Pte. Ltd. acted as financial advisor for AF Global Limited.Reported Earnings • Aug 13First half 2025 earnings released: EPS: S$0.006 (vs S$0.001 loss in 1H 2024)First half 2025 results: EPS: S$0.006 (up from S$0.001 loss in 1H 2024). Revenue: S$394.0m (up 33% from 1H 2024). Net income: S$12.2m (up S$14.5m from 1H 2024). Profit margin: 3.1% (up from net loss in 1H 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.分析記事 • Aug 12Some Confidence Is Lacking In Aspial Corporation Limited's (SGX:A30) P/SSGX:A30 1 Year Share Price vs Fair Value Explore Aspial's Fair Values from the Community and select yours It's not a...New Risk • Aug 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 122% Paying a dividend despite having no free cash flows. Earnings have declined by 21% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change).New Risk • May 20New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: S$128.7m (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 122% Paying a dividend despite having no free cash flows. Earnings have declined by 54% per year over the past 5 years. Minor Risk Market cap is less than US$100m (S$128.7m market cap, or US$99.3m).お知らせ • May 01Aspial Corporation Limited Approves the Final Dividend for the Financial Year Ended 31 December 2024The board of directors (the "Board") of Aspial Corporation Limited (the "Company") is pleased to announced that at the Annual General Meeting ("AGM") of the Company held on 28 April 2025, the company approved the final dividend of 0.30 Singapore cent per ordinary share (tax-exempt one-tier) for the financial year ended 31 December 2024.New Risk • Apr 16New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 122% The company is paying a dividend despite having no free cash flows. Dividend yield: 4.7% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 122% Paying a dividend despite having no free cash flows. Earnings have declined by 54% per year over the past 5 years.New Risk • Apr 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 7,764% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Earnings have declined by 54% per year over the past 5 years. Minor Risk Large one-off items impacting financial results.Reported Earnings • Apr 13Full year 2024 earnings released: EPS: S$0.002 (vs S$0.011 loss in FY 2023)Full year 2024 results: EPS: S$0.002 (up from S$0.011 loss in FY 2023). Revenue: S$678.4m (up 13% from FY 2023). Net income: S$5.45m (up S$29.0m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 14% per year.お知らせ • Apr 11Aspial Corporation Limited, Annual General Meeting, Apr 28, 2025Aspial Corporation Limited, Annual General Meeting, Apr 28, 2025, at 16:00 Singapore Standard Time. Location: aspial one, 55 ubi avenue 3, level 1, singapore 408864, Singapore分析記事 • Feb 25It's A Story Of Risk Vs Reward With Aspial Corporation Limited (SGX:A30)It's not a stretch to say that Aspial Corporation Limited's ( SGX:A30 ) price-to-sales (or "P/S") ratio of 0.2x right...Reported Earnings • Feb 25Full year 2024 earnings released: EPS: S$0.003 (vs S$0.011 loss in FY 2023)Full year 2024 results: EPS: S$0.003 (up from S$0.011 loss in FY 2023). Revenue: S$678.4m (up 13% from FY 2023). Net income: S$5.45m (up S$30.3m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year.New Risk • Dec 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Earnings have declined by 71% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change).Reported Earnings • Aug 15First half 2024 earnings released: S$0.001 loss per share (vs S$0.007 loss in 1H 2023)First half 2024 results: S$0.001 loss per share (improved from S$0.007 loss in 1H 2023). Revenue: S$295.9m (up 4.5% from 1H 2023). Net loss: S$2.32m (loss narrowed 85% from 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.New Risk • Jun 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). Earnings have declined by 73% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (3.0% increase in shares outstanding). Market cap is less than US$100m (S$135.4m market cap, or US$99.8m).分析記事 • Jun 04Aspial Corporation Limited (SGX:A30) Could Be Riskier Than It LooksWith a price-to-sales (or "P/S") ratio of 0.2x Aspial Corporation Limited ( SGX:A30 ) may be sending bullish signals at...お知らせ • Jun 01Aspial Corporation Limited Appoints Tan Seng Chuan as Independent Director, Chairman of the Remuneration Committee and Member of the Audit Committee, Effective from June 1, 2024Aspial Corporation Limited announced the appointment of Tan Seng Chuan as Independent Director, Chairman of the Remuneration Committee and a Member of the Audit Committee, effective from June 1, 2024. Working Experience: November 2017 to Present: TEMBUSU Asia Consulting Pte Ltd. Managing Director August 2015 to October 2017: Ramboll Environ Singapore Pte Ltd. Regional Managing Director (Asia Pacific) January 2010 to February 2015: CH2M HILL Singapore Consulting Pte. Ltd. Regional Director (Asia Pacific) Environmental Services Business Group. Professional Qualifications: Master in Science (Building Science) from the National University of Singapore Bachelor in Engineering (Civil) from the National University of Singapore Diploma in Building Science from the National University of Singapore Professional Engineer registered with the Professional Engineers Board, Singapore Chartered Engineer for Environmental and Water with the Chartered Engineering Board, Singapore Honorary Fellow of the Institution of Engineers, Australia and Singapore. Director Experience Details: World Class Global Limited (delisted from the Official List of the SGX-ST with effect from 8 October 2021) - Independent Director, Chairman of Remuneration Committee and a Member of each Audit Committee, Nominating Committee and Conflicts Resolution Committee. Reason for director to not undergo training: World Class Global Limited (delisted from the Official List of the SGX-ST with effect from 8 October 2021) - Independent Director, Chairman of Remuneration Committee and a Member of each Audit Committee, Nominating Committee and Conflicts Resolution Committee. Other DirectorShips Present: TEMBUSU Asia Consulting Pte Ltd.Reported Earnings • Apr 16Full year 2023 earnings released: S$0.01 loss per share (vs S$0.007 loss in FY 2022)Full year 2023 results: S$0.01 loss per share (further deteriorated from S$0.007 loss in FY 2022). Revenue: S$600.0m (up 19% from FY 2022). Net loss: S$22.2m (loss widened 51% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance.お知らせ • Apr 12Aspial Corporation Limited, Annual General Meeting, Apr 18, 2024Aspial Corporation Limited, Annual General Meeting, Apr 18, 2024, at 17:00 Singapore Standard Time. Location: Aspial One, 55 Ubi Avenue 3, Level 1 Singapore Singapore Agenda: To approve directors' Statement and Audited Financial Statements for the financial year ended 31 December 2023 together with the Independent Auditors' Report thereon; to consider board changes; to approve the Directors' fees of S$266,413 for the financial year ended 31 December 2023; to re-appoint Messrs Ernst & Young LLP as Auditors; to allot and issue new shares; and to consider other matters.分析記事 • Mar 19Is Aspial (SGX:A30) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Feb 24Full year 2023 earnings released: S$0.011 loss per share (vs S$0.007 loss in FY 2022)Full year 2023 results: S$0.011 loss per share (further deteriorated from S$0.007 loss in FY 2022). Revenue: S$600.0m (up 19% from FY 2022). Net loss: S$22.2m (loss widened 51% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.分析記事 • Aug 31These 4 Measures Indicate That Aspial (SGX:A30) Is Using Debt In A Risky WayDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Aug 16First half 2023 earnings released: S$0.007 loss per share (vs S$0 in 1H 2022)First half 2023 results: S$0.007 loss per share (further deteriorated from S$0 in 1H 2022). Revenue: S$283.2m (up 12% from 1H 2022). Net loss: S$15.0m (loss widened S$14.5m from 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance.お知らせ • Aug 12Aspial Corporation Limited Provides Earning Guidance for Half Year Ended 30 June 2023Aspial Corporation Limited provided earning guidance for half year ended 30 June 2023. The Board of Directors announced that following a preliminary review of the unaudited financial results, the Group is expected to report a loss for the half year ended 30 June 2023. The expected loss was due to higher loss incurred for the Group's real estate business. Further details of the Group's financial performance will be disclosed when the Company announces its half year.New Risk • Jul 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.4x net interest cover). Earnings have declined by 44% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (2.6% increase in shares outstanding).Reported Earnings • Apr 16Full year 2022 earnings released: S$0.007 loss per share (vs S$0 in FY 2021)Full year 2022 results: S$0.007 loss per share (further deteriorated from S$0 in FY 2021). Revenue: S$506.2m (up 21% from FY 2021). Net loss: S$14.7m (loss widened S$14.3m from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 01Full year 2022 earnings releasedFull year 2022 results: Revenue: S$506.2m (up 21% from FY 2021). Net loss: S$14.7m (loss widened S$14.3m from FY 2021).Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Independent Non-Executive Director Djuniarti Intan Ng was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.分析記事 • Sep 28Aspial (SGX:A30) Seems To Be Using A Lot Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 09First half 2022 earnings releasedFirst half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (up S$660.0k from 1H 2021). Profit margin: (up from net loss in 1H 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance.Board Change • Jul 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Independent Non-Executive Director Djuniarti Intan Ng was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 28Aspial Corporation Limited Approves Final Dividend for the Financial Year Ended 31 December 2021Aspial Corporation Limited at the annual general meeting held on 29 April 2022, approved the declaration of a final dividend of 0.25 Singapore cent per ordinary share (tax-exempt one-tier) for the financial year ended 31 December 2021.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Independent Non-Executive Director Djuniarti Intan Ng was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 15Full year 2021 earnings released: EPS: S$0 (vs S$0.009 in FY 2020)Full year 2021 results: EPS: S$0 (down from S$0.009 in FY 2020). Revenue: S$417.2m (down 22% from FY 2020). Net loss: S$363.0k (down 102% from profit in FY 2020). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.お知らせ • Apr 14Aspial Corporation Limited, Annual General Meeting, Apr 29, 2022Aspial Corporation Limited, Annual General Meeting, Apr 29, 2022, at 15:00 Singapore Standard Time. Agenda: To receive and adopt the Directors' Statement and the Audited Financial Statements of the company for the financial year ended 31 December 2021 together with the Independent Auditors' Report thereon; to declare a final dividend of 0.25 Singapore cent per ordinary share (tax-exempt one-tier) for the financial year ended 31 December 2021; to re-elect Wong Soon Yum who is retiring pursuant to Regulation 104 of the company's Constitution; to re-elect Ng Bie Tjin @ Djuniarti Intan who is retiring pursuant to Regulation 104 of the company's Constitution and Rule 720(5) of the Listing Manual of the Singapore Exchange Securities Trading Limited; to approve the payment of Directors' fees of SGD 266,000 for the financial year ended 31 December 2021; to re-appoint Messrs Ernst & Young LLP as the Auditors of the Company and to authorise the Directors of the Company to fix their remuneration; and to transact any other ordinary business which may properly be transacted at an AGM.お知らせ • Feb 27Aspial Corporation Limited Proposes One-Tier Tax Exempt Final Dividend for the Financial Year Ended 31 December 2021Aspial Corporation Limited proposed one-tier tax exempt final dividend of 0.25 cents per ordinary share for the financial year ended 31 December 2021 (2020: nil).Reported Earnings • Feb 27Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: S$0 (down from S$0.009 in FY 2020). Revenue: S$417.2m (down 22% from FY 2020). Net loss: S$363.0k (down 102% from profit in FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.お知らせ • Feb 19Aspial Corporation Limited to Report Fiscal Year 2021 Results on Feb 25, 2022Aspial Corporation Limited announced that they will report fiscal year 2021 results After-Market on Feb 25, 2022分析記事 • May 26Does Aspial (SGX:A30) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Apr 19Full year 2020 earnings released: EPS S$0.009 (vs S$0.007 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: S$531.2m (down 5.2% from FY 2019). Net income: S$17.7m (up 40% from FY 2019). Profit margin: 3.3% (up from 2.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.お知らせ • Mar 14Aspial Corporation Limited (SGX:A30) entered into a scheme of arrangement to acquire remaining 18.9% stake in World Class Global Limited (Catalist:1E6) (ECG) from Koh Wee Seng, Ng Sheng Tiong, Ng Bie Tjin and others for SGD 26.8 million.Aspial Corporation Limited (SGX:A30) entered into a scheme of arrangement to acquire remaining 18.9% stake in World Class Global Limited (Catalist:1E6) (ECG) from Koh Wee Seng, Ng Sheng Tiong, Ng Bie Tjin and others for SGD 26.8 million on March 12, 2021. As part of the transaction, Aspial Corporation will purchase 173.04 million shares of World Class Global Limited at an exchange ratio of 1.1052 new ordinary shares of Aspial Corporation Limited for an each share of World Class Global, which will result in the allotment and issuance of up to 191,261,147 new Aspial Shares. Pre transaction, Aspial Corporation Limited holds 742,828,700 WCG Shares representing 81.11% stake of the total issued WCG Shares and Koh Wee Seng, Ng Sheng Tiong and Ng Bie Tjin holds 1.15%, 1.13% and 0.05% stake, respectively. Upon the Scheme becoming effective, World Class Global Limited will be delist from stock exchange. The transaction is subject to regulatory approval including approval of SGX-ST and Foreign Investment Review Board approval under the Australian Foreign Acquisitions and Takeovers Act 1975, court approval, approval of shareholders of Aspial Corporation and the approval of the Scheme by a majority in number of Shareholders of World Class Global representing three-fourths in value of the Scheme Shares held by Scheme Shareholders. If any of the conditions are not satisfied, or if the Scheme has not become effective in accordance with its terms on or before 5 p.m. on the date falling five (5) months from announcement date or such other date as may be agreed in writing between the Offeror and the Company (the “Cut-Off Date”), either party may immediately terminate this agreement. SAC Capital Private Limited acted as financial advisor to Aspial Corporation Limited. Xandar Capital Pte. Ltd. acted as financial advisor to WCG. RHT Capital Pte. Ltd. acted as financial advisor to the directors of Aspial Corporation.分析記事 • Mar 03We Think That There Are Some Issues For Aspial (SGX:A30) Beyond Its Promising EarningsAspial Corporation Limited's ( SGX:A30 ) healthy profit numbers didn't contain any surprises for investors. We believe...お知らせ • Feb 25Aspial Corporation Limited Announces No Dividend for the Financial Year Ended December 31, 2020Aspial Corporation Limited announced in view of the economic uncertainties caused by COVID-19 pandemic, no dividend has been declared for the current financial year ended December 31, 2020 as the Group intends to retain cash for its working capital, to reduce its borrowings and fund any potential growth opportunities in future.分析記事 • Feb 25Is Aspial (SGX:A30) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Feb 25Full year 2020 earnings released: EPS S$0.009 (vs S$0.007 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: S$531.6m (down 5.1% from FY 2019). Net income: S$17.7m (up 40% from FY 2019). Profit margin: 3.3% (up from 2.3% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 17% per year.お知らせ • Feb 10Aspial Corporation Limited to Report Fiscal Year 2020 Results on Feb 24, 2021Aspial Corporation Limited announced that they will report fiscal year 2020 results After-Market on Feb 24, 2021分析記事 • Dec 06What Type Of Returns Would Aspial's(SGX:A30) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?Aspial Corporation Limited ( SGX:A30 ) shareholders should be happy to see the share price up 15% in the last quarter... このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Aspial は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測SGX:A30 - アナリストの将来予測と過去の財務データ ( )SGD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202587621-2612N/A9/30/202582620-40-14N/A6/30/202577720-55-40N/A3/31/202572713-56-39N/A12/31/20246783-58-38N/A9/30/2024646-4-32-12N/A6/30/2024613-11-513N/A3/31/2024606-17925N/A12/31/2023600-242337N/A9/30/2023569-261327N/A6/30/2023537-29417N/A3/31/2023522-22320N/A12/31/2022506-15222N/A9/30/2022488-7-217N/A6/30/20224700-612N/A3/31/20224430-29-2N/A12/31/20214170-52-15N/A9/30/20214576-2313N/A6/30/202149712541N/A3/31/20215141573109N/A12/31/202053118142177N/A9/30/20204924123166N/A6/30/2020482374123N/A3/31/20205031175115N/A12/31/20195601371101N/A9/30/201957517N/A180N/A6/30/201978430N/A375N/A3/31/201985925N/A287N/A12/31/201889828N/A271N/A9/30/201891037N/A59N/A6/30/201867119N/A-133N/A3/31/20185626N/A-153N/A12/31/20174905N/A-199N/A9/30/2017535-8N/A-67N/A6/30/20175914N/A-109N/A3/31/20176364N/A-29N/A12/31/20166211N/A5N/A9/30/201656714N/A-34N/A6/30/20165363N/A-12N/A3/31/20164909N/A22N/A12/31/20154649N/A-22N/A9/30/201546810N/A-23N/A6/30/201546516N/A-67N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A30の予測収益成長が 貯蓄率 ( 2.6% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A30の収益がSG市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A30の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A30の収益がSG市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A30の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A30の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YRetail 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 02:07終値2026/05/21 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Aspial Corporation Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 12Aspial Corporation Limited Provides Earning Guidance for Half Year Ended 30 June 2023Aspial Corporation Limited provided earning guidance for half year ended 30 June 2023. The Board of Directors announced that following a preliminary review of the unaudited financial results, the Group is expected to report a loss for the half year ended 30 June 2023. The expected loss was due to higher loss incurred for the Group's real estate business. Further details of the Group's financial performance will be disclosed when the Company announces its half year.
Reported Earnings • Apr 17Full year 2025 earnings released: EPS: S$0.01 (vs S$0.002 in FY 2024)Full year 2025 results: EPS: S$0.01 (up from S$0.002 in FY 2024). Revenue: S$875.8m (up 29% from FY 2024). Net income: S$21.5m (up S$18.0m from FY 2024). Profit margin: 2.5% (up from 0.5% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
お知らせ • Apr 16Aspial Corporation Limited (SGX:A30) and Koh Wee Meng completed the acquisition of remaining 20.16% stake in AF Global Limited (SGX:L38).Aspial Corporation Limited (SGX:A30) and Koh Wee Meng entered into an implementation agreement to acquire remaining 20.16% stake in AF Global Limited (SGX:L38) for SGD 23.4 million on October 8, 2025. A cash consideration valued at SGD 0.11 per share will be paid by Aspial Corporation Limited. As at the Joint Announcement Date, Aspial has a direct interest in 440,691,785 Shares, representing 41.75% stake and KWM has a direct interest in 326,265,000 Shares, representing 30.91% stake in AF Global. Based on information available to the Offeror as at the Joint Announcement Date, 75,855,637 Shares representing approximately 7.19% of the total number of Shares are held by persons who are deemed to be “interested persons” (as defined in the listing manual of the SGX-ST) of Aspial. The Related Shareholders are presumed to be concert parties of the Offeror under the Code and will abstain from voting on the Scheme in accordance with the requirements of the Securities Industry Council’s. DBS, as the sole financial adviser to the Offeror, confirms that sufficient financial resources are available to the Offeror to satisfy in full the aggregate Scheme Consideration payable by the Offeror for all the Scheme Shares to be acquired by the Offeror pursuant to the Scheme. The transaction is subject to approval of the Scheme by a majority in number of the Scheme Shareholders representing three-fourths in value of the Scheme Shares held by Scheme Shareholders present and voting either in person or by proxy at the Scheme Meeting, The Offeror and its concert parties, and the common substantial shareholders of the Offeror and the Company will abstain from voting on the Scheme, Court sanction for convening the Scheme Meeting; and (ii) the approval of the Scheme (if approved at the Scheme Meeting). The transaction is expected to complete in first quarter of 2026. As of January 15, 2026, the court has granted approval for the transaction. As of January 15, 2026, AF Global board announced that it has dispatched scheme document to shareholders. Shareholders meeting will be held on February 5, 2026. As of February 4, 2026, AF Global Limited announced the postpone of shareholders meeting from February 5, 2026, to March 10, 2026. As of February 12, 2026, AF Global Limited announced that SGX-ST informed that it has no objection to AF Global Waiver Application. On March 10, 2026, the shareholders of AF Global Limited has approved the transaction. The transaction is now expected to close on or around April 8, 2026. As per the announcement dated March 27, 2026 the court has sanctioned the Scheme. The transaction is now expected to close on April 14, 2026. DBS Bank Ltd. acted as financial advisor for Aspial Corporation and Koh Wee Meng. Xandar Capital Pte. Ltd. acted as financial advisor for AF Global Limited. Evolve Capital Asia acted as financial advisor to directors of Aspial. Venture Law LLC acted as legal advisor for AF Global Limited. Aspial Corporation Limited (SGX:A30) and Koh Wee Meng completed the acquisition of remaining 20.16% stake in AF Global Limited (SGX:L38) on April 15, 2026.
New Risk • Apr 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.5x net interest cover). Minor Risk Share price has been volatile over the past 3 months (9.1% average weekly change).
お知らせ • Apr 14Aspial Corporation Limited, Annual General Meeting, Apr 28, 2026Aspial Corporation Limited, Annual General Meeting, Apr 28, 2026, at 16:00 Singapore Standard Time. Location: aspial one, 55 ubi avenue 3, level 1, singapore 408864, Singapore
Reported Earnings • Feb 26Full year 2025 earnings released: EPS: S$0.01 (vs S$0.002 in FY 2024)Full year 2025 results: EPS: S$0.01 (up from S$0.002 in FY 2024). Revenue: S$875.8m (up 29% from FY 2024). Net income: S$21.5m (up 294% from FY 2024). Profit margin: 2.5% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
分析記事 • Jan 15With Aspial Corporation Limited (SGX:A30) It Looks Like You'll Get What You Pay ForWith a median price-to-sales (or "P/S") ratio of close to 0.7x in the Specialty Retail industry in Singapore, you could...
お知らせ • Oct 08Aspial Corporation Limited (SGX:A30) and Koh Wee Meng entered into an implementation agreement to acquire remaining 20.16% stake in AF Global Limited (SGX:L38) for SGD 23.4 million.Aspial Corporation Limited (SGX:A30) and Koh Wee Meng entered into an implementation agreement to acquire remaining 20.16% stake in AF Global Limited (SGX:L38) for SGD 23.4 million on October 8, 2025. A cash consideration valued at SGD 0.11 per share will be paid by Aspial Corporation Limited. As at the Joint Announcement Date, Aspial has a direct interest in 440,691,785 Shares, representing 41.75% stake and KWM has a direct interest in 326,265,000 Shares, representing 30.91% stake in AF Global. Based on information available to the Offeror as at the Joint Announcement Date, 75,855,637 Shares representing approximately 7.19% of the total number of Shares are held by persons who are deemed to be “interested persons” (as defined in the listing manual of the SGX-ST) of Aspial. The Related Shareholders are presumed to be concert parties of the Offeror under the Code and will abstain from voting on the Scheme in accordance with the requirements of the Securities Industry Council’s. DBS, as the sole financial adviser to the Offeror, confirms that sufficient financial resources are available to the Offeror to satisfy in full the aggregate Scheme Consideration payable by the Offeror for all the Scheme Shares to be acquired by the Offeror pursuant to the Scheme. The transaction is subject to approval of the Scheme by a majority in number of the Scheme Shareholders representing three-fourths in value of the Scheme Shares held by Scheme Shareholders present and voting either in person or by proxy at the Scheme Meeting, The Offeror and its concert parties, and the common substantial shareholders of the Offeror and the Company will abstain from voting on the Scheme, Court sanction for convening the Scheme Meeting; and (ii) the approval of the Scheme (if approved at the Scheme Meeting). The transaction is expected to complete in first quarter of 2026. DBS Bank Ltd. acted as financial advisor for Aspial Corporation and Koh Wee Meng. Xandar Capital Pte. Ltd. acted as financial advisor for AF Global Limited.
Reported Earnings • Aug 13First half 2025 earnings released: EPS: S$0.006 (vs S$0.001 loss in 1H 2024)First half 2025 results: EPS: S$0.006 (up from S$0.001 loss in 1H 2024). Revenue: S$394.0m (up 33% from 1H 2024). Net income: S$12.2m (up S$14.5m from 1H 2024). Profit margin: 3.1% (up from net loss in 1H 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
分析記事 • Aug 12Some Confidence Is Lacking In Aspial Corporation Limited's (SGX:A30) P/SSGX:A30 1 Year Share Price vs Fair Value Explore Aspial's Fair Values from the Community and select yours It's not a...
New Risk • Aug 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 122% Paying a dividend despite having no free cash flows. Earnings have declined by 21% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.8% average weekly change).
New Risk • May 20New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: S$128.7m (US$99.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 122% Paying a dividend despite having no free cash flows. Earnings have declined by 54% per year over the past 5 years. Minor Risk Market cap is less than US$100m (S$128.7m market cap, or US$99.3m).
お知らせ • May 01Aspial Corporation Limited Approves the Final Dividend for the Financial Year Ended 31 December 2024The board of directors (the "Board") of Aspial Corporation Limited (the "Company") is pleased to announced that at the Annual General Meeting ("AGM") of the Company held on 28 April 2025, the company approved the final dividend of 0.30 Singapore cent per ordinary share (tax-exempt one-tier) for the financial year ended 31 December 2024.
New Risk • Apr 16New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 122% The company is paying a dividend despite having no free cash flows. Dividend yield: 4.7% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Dividend is not well covered by earnings and cash flows. Payout ratio: 122% Paying a dividend despite having no free cash flows. Earnings have declined by 54% per year over the past 5 years.
New Risk • Apr 13New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 7,764% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Earnings have declined by 54% per year over the past 5 years. Minor Risk Large one-off items impacting financial results.
Reported Earnings • Apr 13Full year 2024 earnings released: EPS: S$0.002 (vs S$0.011 loss in FY 2023)Full year 2024 results: EPS: S$0.002 (up from S$0.011 loss in FY 2023). Revenue: S$678.4m (up 13% from FY 2023). Net income: S$5.45m (up S$29.0m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 14% per year.
お知らせ • Apr 11Aspial Corporation Limited, Annual General Meeting, Apr 28, 2025Aspial Corporation Limited, Annual General Meeting, Apr 28, 2025, at 16:00 Singapore Standard Time. Location: aspial one, 55 ubi avenue 3, level 1, singapore 408864, Singapore
分析記事 • Feb 25It's A Story Of Risk Vs Reward With Aspial Corporation Limited (SGX:A30)It's not a stretch to say that Aspial Corporation Limited's ( SGX:A30 ) price-to-sales (or "P/S") ratio of 0.2x right...
Reported Earnings • Feb 25Full year 2024 earnings released: EPS: S$0.003 (vs S$0.011 loss in FY 2023)Full year 2024 results: EPS: S$0.003 (up from S$0.011 loss in FY 2023). Revenue: S$678.4m (up 13% from FY 2023). Net income: S$5.45m (up S$30.3m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year.
New Risk • Dec 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). Earnings have declined by 71% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change).
Reported Earnings • Aug 15First half 2024 earnings released: S$0.001 loss per share (vs S$0.007 loss in 1H 2023)First half 2024 results: S$0.001 loss per share (improved from S$0.007 loss in 1H 2023). Revenue: S$295.9m (up 4.5% from 1H 2023). Net loss: S$2.32m (loss narrowed 85% from 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
New Risk • Jun 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Singaporean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). Earnings have declined by 73% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (3.0% increase in shares outstanding). Market cap is less than US$100m (S$135.4m market cap, or US$99.8m).
分析記事 • Jun 04Aspial Corporation Limited (SGX:A30) Could Be Riskier Than It LooksWith a price-to-sales (or "P/S") ratio of 0.2x Aspial Corporation Limited ( SGX:A30 ) may be sending bullish signals at...
お知らせ • Jun 01Aspial Corporation Limited Appoints Tan Seng Chuan as Independent Director, Chairman of the Remuneration Committee and Member of the Audit Committee, Effective from June 1, 2024Aspial Corporation Limited announced the appointment of Tan Seng Chuan as Independent Director, Chairman of the Remuneration Committee and a Member of the Audit Committee, effective from June 1, 2024. Working Experience: November 2017 to Present: TEMBUSU Asia Consulting Pte Ltd. Managing Director August 2015 to October 2017: Ramboll Environ Singapore Pte Ltd. Regional Managing Director (Asia Pacific) January 2010 to February 2015: CH2M HILL Singapore Consulting Pte. Ltd. Regional Director (Asia Pacific) Environmental Services Business Group. Professional Qualifications: Master in Science (Building Science) from the National University of Singapore Bachelor in Engineering (Civil) from the National University of Singapore Diploma in Building Science from the National University of Singapore Professional Engineer registered with the Professional Engineers Board, Singapore Chartered Engineer for Environmental and Water with the Chartered Engineering Board, Singapore Honorary Fellow of the Institution of Engineers, Australia and Singapore. Director Experience Details: World Class Global Limited (delisted from the Official List of the SGX-ST with effect from 8 October 2021) - Independent Director, Chairman of Remuneration Committee and a Member of each Audit Committee, Nominating Committee and Conflicts Resolution Committee. Reason for director to not undergo training: World Class Global Limited (delisted from the Official List of the SGX-ST with effect from 8 October 2021) - Independent Director, Chairman of Remuneration Committee and a Member of each Audit Committee, Nominating Committee and Conflicts Resolution Committee. Other DirectorShips Present: TEMBUSU Asia Consulting Pte Ltd.
Reported Earnings • Apr 16Full year 2023 earnings released: S$0.01 loss per share (vs S$0.007 loss in FY 2022)Full year 2023 results: S$0.01 loss per share (further deteriorated from S$0.007 loss in FY 2022). Revenue: S$600.0m (up 19% from FY 2022). Net loss: S$22.2m (loss widened 51% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 12Aspial Corporation Limited, Annual General Meeting, Apr 18, 2024Aspial Corporation Limited, Annual General Meeting, Apr 18, 2024, at 17:00 Singapore Standard Time. Location: Aspial One, 55 Ubi Avenue 3, Level 1 Singapore Singapore Agenda: To approve directors' Statement and Audited Financial Statements for the financial year ended 31 December 2023 together with the Independent Auditors' Report thereon; to consider board changes; to approve the Directors' fees of S$266,413 for the financial year ended 31 December 2023; to re-appoint Messrs Ernst & Young LLP as Auditors; to allot and issue new shares; and to consider other matters.
分析記事 • Mar 19Is Aspial (SGX:A30) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Feb 24Full year 2023 earnings released: S$0.011 loss per share (vs S$0.007 loss in FY 2022)Full year 2023 results: S$0.011 loss per share (further deteriorated from S$0.007 loss in FY 2022). Revenue: S$600.0m (up 19% from FY 2022). Net loss: S$22.2m (loss widened 51% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance.
分析記事 • Aug 31These 4 Measures Indicate That Aspial (SGX:A30) Is Using Debt In A Risky WayDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Aug 16First half 2023 earnings released: S$0.007 loss per share (vs S$0 in 1H 2022)First half 2023 results: S$0.007 loss per share (further deteriorated from S$0 in 1H 2022). Revenue: S$283.2m (up 12% from 1H 2022). Net loss: S$15.0m (loss widened S$14.5m from 1H 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 12Aspial Corporation Limited Provides Earning Guidance for Half Year Ended 30 June 2023Aspial Corporation Limited provided earning guidance for half year ended 30 June 2023. The Board of Directors announced that following a preliminary review of the unaudited financial results, the Group is expected to report a loss for the half year ended 30 June 2023. The expected loss was due to higher loss incurred for the Group's real estate business. Further details of the Group's financial performance will be disclosed when the Company announces its half year.
New Risk • Jul 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.4x net interest cover). Earnings have declined by 44% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (2.6% increase in shares outstanding).
Reported Earnings • Apr 16Full year 2022 earnings released: S$0.007 loss per share (vs S$0 in FY 2021)Full year 2022 results: S$0.007 loss per share (further deteriorated from S$0 in FY 2021). Revenue: S$506.2m (up 21% from FY 2021). Net loss: S$14.7m (loss widened S$14.3m from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 69 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 01Full year 2022 earnings releasedFull year 2022 results: Revenue: S$506.2m (up 21% from FY 2021). Net loss: S$14.7m (loss widened S$14.3m from FY 2021).
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Independent Non-Executive Director Djuniarti Intan Ng was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Sep 28Aspial (SGX:A30) Seems To Be Using A Lot Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 09First half 2022 earnings releasedFirst half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (up S$660.0k from 1H 2021). Profit margin: (up from net loss in 1H 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance.
Board Change • Jul 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Independent Non-Executive Director Djuniarti Intan Ng was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 28Aspial Corporation Limited Approves Final Dividend for the Financial Year Ended 31 December 2021Aspial Corporation Limited at the annual general meeting held on 29 April 2022, approved the declaration of a final dividend of 0.25 Singapore cent per ordinary share (tax-exempt one-tier) for the financial year ended 31 December 2021.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Independent Non-Executive Director Djuniarti Intan Ng was the last director to join the board, commencing their role in 2014. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 15Full year 2021 earnings released: EPS: S$0 (vs S$0.009 in FY 2020)Full year 2021 results: EPS: S$0 (down from S$0.009 in FY 2020). Revenue: S$417.2m (down 22% from FY 2020). Net loss: S$363.0k (down 102% from profit in FY 2020). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 14Aspial Corporation Limited, Annual General Meeting, Apr 29, 2022Aspial Corporation Limited, Annual General Meeting, Apr 29, 2022, at 15:00 Singapore Standard Time. Agenda: To receive and adopt the Directors' Statement and the Audited Financial Statements of the company for the financial year ended 31 December 2021 together with the Independent Auditors' Report thereon; to declare a final dividend of 0.25 Singapore cent per ordinary share (tax-exempt one-tier) for the financial year ended 31 December 2021; to re-elect Wong Soon Yum who is retiring pursuant to Regulation 104 of the company's Constitution; to re-elect Ng Bie Tjin @ Djuniarti Intan who is retiring pursuant to Regulation 104 of the company's Constitution and Rule 720(5) of the Listing Manual of the Singapore Exchange Securities Trading Limited; to approve the payment of Directors' fees of SGD 266,000 for the financial year ended 31 December 2021; to re-appoint Messrs Ernst & Young LLP as the Auditors of the Company and to authorise the Directors of the Company to fix their remuneration; and to transact any other ordinary business which may properly be transacted at an AGM.
お知らせ • Feb 27Aspial Corporation Limited Proposes One-Tier Tax Exempt Final Dividend for the Financial Year Ended 31 December 2021Aspial Corporation Limited proposed one-tier tax exempt final dividend of 0.25 cents per ordinary share for the financial year ended 31 December 2021 (2020: nil).
Reported Earnings • Feb 27Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: S$0 (down from S$0.009 in FY 2020). Revenue: S$417.2m (down 22% from FY 2020). Net loss: S$363.0k (down 102% from profit in FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 19Aspial Corporation Limited to Report Fiscal Year 2021 Results on Feb 25, 2022Aspial Corporation Limited announced that they will report fiscal year 2021 results After-Market on Feb 25, 2022
分析記事 • May 26Does Aspial (SGX:A30) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Apr 19Full year 2020 earnings released: EPS S$0.009 (vs S$0.007 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: S$531.2m (down 5.2% from FY 2019). Net income: S$17.7m (up 40% from FY 2019). Profit margin: 3.3% (up from 2.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 22% per year, which means it is performing significantly worse than earnings.
お知らせ • Mar 14Aspial Corporation Limited (SGX:A30) entered into a scheme of arrangement to acquire remaining 18.9% stake in World Class Global Limited (Catalist:1E6) (ECG) from Koh Wee Seng, Ng Sheng Tiong, Ng Bie Tjin and others for SGD 26.8 million.Aspial Corporation Limited (SGX:A30) entered into a scheme of arrangement to acquire remaining 18.9% stake in World Class Global Limited (Catalist:1E6) (ECG) from Koh Wee Seng, Ng Sheng Tiong, Ng Bie Tjin and others for SGD 26.8 million on March 12, 2021. As part of the transaction, Aspial Corporation will purchase 173.04 million shares of World Class Global Limited at an exchange ratio of 1.1052 new ordinary shares of Aspial Corporation Limited for an each share of World Class Global, which will result in the allotment and issuance of up to 191,261,147 new Aspial Shares. Pre transaction, Aspial Corporation Limited holds 742,828,700 WCG Shares representing 81.11% stake of the total issued WCG Shares and Koh Wee Seng, Ng Sheng Tiong and Ng Bie Tjin holds 1.15%, 1.13% and 0.05% stake, respectively. Upon the Scheme becoming effective, World Class Global Limited will be delist from stock exchange. The transaction is subject to regulatory approval including approval of SGX-ST and Foreign Investment Review Board approval under the Australian Foreign Acquisitions and Takeovers Act 1975, court approval, approval of shareholders of Aspial Corporation and the approval of the Scheme by a majority in number of Shareholders of World Class Global representing three-fourths in value of the Scheme Shares held by Scheme Shareholders. If any of the conditions are not satisfied, or if the Scheme has not become effective in accordance with its terms on or before 5 p.m. on the date falling five (5) months from announcement date or such other date as may be agreed in writing between the Offeror and the Company (the “Cut-Off Date”), either party may immediately terminate this agreement. SAC Capital Private Limited acted as financial advisor to Aspial Corporation Limited. Xandar Capital Pte. Ltd. acted as financial advisor to WCG. RHT Capital Pte. Ltd. acted as financial advisor to the directors of Aspial Corporation.
分析記事 • Mar 03We Think That There Are Some Issues For Aspial (SGX:A30) Beyond Its Promising EarningsAspial Corporation Limited's ( SGX:A30 ) healthy profit numbers didn't contain any surprises for investors. We believe...
お知らせ • Feb 25Aspial Corporation Limited Announces No Dividend for the Financial Year Ended December 31, 2020Aspial Corporation Limited announced in view of the economic uncertainties caused by COVID-19 pandemic, no dividend has been declared for the current financial year ended December 31, 2020 as the Group intends to retain cash for its working capital, to reduce its borrowings and fund any potential growth opportunities in future.
分析記事 • Feb 25Is Aspial (SGX:A30) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Feb 25Full year 2020 earnings released: EPS S$0.009 (vs S$0.007 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: S$531.6m (down 5.1% from FY 2019). Net income: S$17.7m (up 40% from FY 2019). Profit margin: 3.3% (up from 2.3% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 17% per year.
お知らせ • Feb 10Aspial Corporation Limited to Report Fiscal Year 2020 Results on Feb 24, 2021Aspial Corporation Limited announced that they will report fiscal year 2020 results After-Market on Feb 24, 2021
分析記事 • Dec 06What Type Of Returns Would Aspial's(SGX:A30) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?Aspial Corporation Limited ( SGX:A30 ) shareholders should be happy to see the share price up 15% in the last quarter...